Ng Sam, Rigau Valérie, Moritz-Gasser Sylvie, Gozé Catherine, Darlix Amélie, Herbet Guillaume, Duffau Hugues
Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 80 Av Augustin Fliche, 34295, Montpellier, France.
Institute of Functional Genomics, University of Montpellier, INSERM, CNRS, Team "Plasticity of Central Nervous System, Stem Cells and Glial Tumors,", National Institute for Health and Medical Research (INSERM), U1191 Laboratory, 34091, Montpellier, France.
Lancet Reg Health Eur. 2024 Sep 20;46:101078. doi: 10.1016/j.lanepe.2024.101078. eCollection 2024 Nov.
In isocitrate dehydrogenase (IDH)-mutant low-grade gliomas (LGGs), awake functional-based resection (i.e., resection based on intraoperative functional responses rather than anatomical margins) has emerged as an efficient method to reduce tumour volume (TV) while minimizing postoperative deficits. Here, our goal was to assess the long-term onco-functional outcomes after awake functional-based resection in IDH-mutant LGGs, in conjunction with clinico-radiological and molecular factors.
We retrospectively studied a consecutive cohort (June 1997-January 2023) of 949 patients. Six hundred patients with IDH-mutant LGGs benefited from an awake functional-based resection with a median follow-up of 7.8 years (95% Confidence interval [CI]: 7.1-8.4 years). The main outcomes were the overall survival (OS), the OS with Karnofsky performance status ≥80% (OS ), cognition measures, and professional activities at 12 months post-surgery.
600 patients were included in the cohort (274 female [46.0%], median age: 36 years [Interquartile range, IQR: 30-44 years]). The rate of return to work was 93.7%. The impact of surgery on cognition was of limited magnitude. The median postsurgical TV of 2.5 mL (IQR: 0-8.0 mL). The median OS was over 20 years (median: NA, 95% CI: 17.0-NA years). The median OS was 14.7 years (95% CI: 13.2-17.2 years). Factors associated with longer OS and OS were 1p19q codeletion (Hazard ratio [HR]: 0.27, 95% CI: 0.16-0.43, HR :0.25, 95% CI: 0.17-0.36), supratotal resection (HR: 0.08, 95% CI: 0.005-0.40, HR :0.12, 95% CI: 0.03-0.34) and total resection (HR: 0.31, 95% CI: 0.16-0.59, HR :0.21, 95% CI: 0.12-0.36). Recursive partitioning analyses established three OS and OS prognostic groups, highlighting the contributions of histomolecular status, extent of resection, postsurgical and presurgical TV. Further propensity-matching analyses confirmed the oncological benefits of supratotal resections.
Awake functional-based resection surgery in newly diagnosed IDH-mutant grade 2 LGG, was an effective strategy associated with long survival (median OS over 20 years) and long-term preservation of autonomy. More complete tumor resections favored better onco-functional outcomes across all molecularly-defined subtypes. Short-term effects were of limited magnitude regarding postoperative cognitive and professional outcomes. Supratotal functional-based resections offered additional survival benefits.
None.
在异柠檬酸脱氢酶(IDH)突变的低级别胶质瘤(LGG)中,清醒状态下基于功能的切除术(即基于术中功能反应而非解剖边界的切除术)已成为一种有效方法,可在减少肿瘤体积(TV)的同时,将术后功能缺损降至最低。在此,我们的目标是结合临床放射学和分子因素,评估IDH突变型LGG患者在清醒状态下基于功能的切除术后的长期肿瘤功能结局。
我们回顾性研究了连续队列(1997年6月至2023年1月)中的949例患者。600例IDH突变型LGG患者接受了清醒状态下基于功能的切除术,中位随访时间为7.8年(95%置信区间[CI]:7.1 - 8.4年)。主要结局包括总生存期(OS)、卡氏功能状态评分≥80%时的总生存期(OS )、认知指标以及术后12个月的职业活动情况。
该队列纳入了600例患者(274例女性[46.0%],中位年龄:36岁[四分位间距,IQR:30 - 44岁])。重返工作岗位的比例为93.7%。手术对认知的影响程度有限。术后肿瘤体积中位数为2.5 mL(IQR:0 - 8.0 mL)。中位总生存期超过20年(中位数:无可用数据,95% CI:17.0 - 无可用数据年)。中位OS 为14.7年(95% CI:13.2 - 17.2年)。与较长总生存期和OS 相关的因素包括1p19q共缺失(风险比[HR]:0.27,95% CI:0.16 - 0.43,HR :0.25,95% CI:0.17 - 0.36)、次全切除(HR:0.08,95% CI:0.005 - 0.40,HR :0.12,95% CI:0.03 - 0.34)和全切除(HR:0.31,95% CI:0.16 - 0.59,HR :0.21,95% CI:0.12 - 0.36)。递归划分分析确定了三个总生存期和OS 预后组,突出了组织分子状态、切除范围、术后和术前肿瘤体积的作用。进一步的倾向匹配分析证实了次全切除的肿瘤学益处。
新诊断的IDH突变型2级LGG患者在清醒状态下进行基于功能的切除手术,是一种有效的策略,与长期生存(中位总生存期超过20年)和长期自主性保留相关。更彻底的肿瘤切除有利于所有分子定义亚型获得更好的肿瘤功能结局。术后认知和职业结局方面的短期影响程度有限。基于功能的次全切除提供了额外的生存益处。
无。